Yesterday
HMC Capital chooses battery storage for first climate investment
David Di Pilla’s asset manager will pay up to $50 million for a controlling stake in StorEnergy, which is headed by a former Spark Infrastructure executive.
- Opinion
- Competition
Could this be the country’s stupidest public policymaking debacle?
From a regulator which has declared it can’t do anything to a company – PEXA – transparently trying to keep its monopoly, there’s not much that can compare.
This Month
UBS has a new suggestion for REIT investors – buy battered Mirvac
The bank’s analysts, in a 65-page overview of the sector, said the market had yet to confront the impact of higher interest rates. It expects two increases.
Local REITs outpace broader market despite sagging asset valuations
Goodman Group was the standout performer in the 12 months to June 30, buoyed by rising demand from investors for exposure to data centres.
- Updated
June
BHP accuses class action law firm of ‘losing’ 100,000 claimants
BHP lost its claim to have 33,000 claimants struck out of the class action it is defending over the 2015 Mariana dam disaster, but the overall figure still slipped from 700,000 to 600,000.
Pilbara gold miner Calidus collapses as Macquarie calls in receivers
The ASX-listed company runs the Warrawoona mine near Marble Bar in Western Australia and was working with SQM to develop the Pirra lithium project.
Southern Cross rejects Catalano’s offer to sell his newspapers
The operator of regional television networks and the Hit and Triple M radio brands says it does not want to buy a portfolio of regional publications.
- Updated
Myer outlines massive expansion plan with Just Jeans, Jay Jays buy
The department store has proposed acquiring several brands owned by Solomon Lew’s Premier Investments, its largest shareholder, in a bid to trigger growth.
QBE nears end of the road on reset as it ditches US middle-market
The ASX-listed insurance giant is hoping to shake off the last vestiges of a decade-long but ill-fated grab at the North American market with the wind down.
Integral Diagnostics dealmaking creates $1b diagnostics giant
The company has proposed a merger with its smaller rival, Capitol Health, creating the largest pure-play diagnostics imaging group on the ASX.
- Exclusive
- Mergers & acquisitions
Singapore’s Temasek snaps up $300m stake in ETF provider Betashares
The privately owned, Sydney-headquartered firm is one of the largest local providers of exchange-traded fund products with $38 billion under management.
Telix pulls $300m Nasdaq IPO as investors demand deep discount
The cancer treatment hopeful had announced plans to list in New York only last week as it searched for more capital. On Friday, it withdrew from the initial public offering.
Origin Energy to trim green assets to boost returns
Origin Energy chief executive Frank Calabria says the country’s largest electricity utility will minimise the company’s ownership of wind and solar generation assets as part of a strategy to boost investor returns.
- Exclusive
- Energy
Warning on Labor’s flagship emissions scheme
The CEO of a major coal and gas utility says the government’s flagship policy could be too slow in supporting the developments needed to hit emission reduction targets.
- Updated
- Energy
AGL goes big on ‘smart’ energy platform with $150m Kaluza stake
Its major rival, Origin Energy, has made a highly successful investment in a similar business, Octopus Energy. The platform co-ordinates supply and billing.
- Updated
Cranbrook settles with former headmaster, but ABC in line of fire
Nicholas Sampson says he has been “vindicated”, but he still has an axe to grind with the national broadcaster over its “Four Corners” program.
IDP Education dives on fears international students will stay away
The country’s largest listed provider of international education services says the restrictions in Australia, Canada and the UK are “linked to election cycles”.
Immutep raises $100m and signs with Merck on ‘blockbuster’ drug
Shares in the oncology therapy hopeful have risen some 45 per cent in the last 12 months as the company nears the commercialisation of its drug, Efti.
- Exclusive
- Hong Kong protests
Ex-Crosby Textor pollster ‘deeply uncomfortable’ with Hong Kong work
The think tank which commissioned the research was founded by city’s former chief executive who remained a part of the Chinese People’s Political Consultative Conference.
- Exclusive
- Hong Kong protests
Crosby Textor advised pro-Beijing HK officials
The Australian political consultancy provided advice used by pro-Beijing officials in Hong Kong ahead of the start of national security laws that dramatically curtailed free speech.
